XOMA and LGND Related Headlines
Go Back- Ligand to acquire XOMA Royalty for $739 million in cash deal
- Ligand to acquire XOMA Royalty for $739 million in cash deal
- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
- Ligand Pharma (LGND) to buy Xoma for ~$740M - WSJ
XOMA and LGND Related Press Releases
Go Back- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
